Edgewise Therapeutics Inc (EWTX)
Edgewise Therapeutics - Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)
Edgewise Therapeutics - Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)
Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody
Best Buy Canada Selects Perion as a Full-Stack Partner to Power its Retail DOOH Media Network
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial
FORM 6-K- Company Presentation
Verizon rompe el molde de la industria de telecomunicaciones dando prioridad a sus clientes
NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer
ReposiTrak Traceability Network®, the World’s Largest Food Traceability Network, Surpasses 8.2 Million Supplier Records Collected
Palladyne AI Deploys True Autonomy Drone-Swarming Software, SwarmOS™, During U.S. Army 4th Infantry Division Ivy Mass Exercise